Mithra Pharmaceuticals S.A.
MITPF · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $422,123 | $309,262 | $912,793 | $614,360 |
| - Cash | $8,980 | $28,285 | $32,872 | $138,675 |
| + Debt | $212,314 | $245,802 | $238,164 | $328,640 |
| Enterprise Value | $625,457 | $526,779 | $1,118,085 | $804,325 |
| Revenue | $40,155 | $66,997 | $22,668 | $9,030 |
| % Growth | -40.1% | 195.6% | 151% | – |
| Gross Profit | $5,991 | $35,434 | -$3,482 | -$4,300 |
| % Margin | 14.9% | 52.9% | -15.4% | -47.6% |
| EBITDA | -$52,771 | $17,462 | -$82,260 | -$80,380 |
| % Margin | -131.4% | 26.1% | -362.9% | -890.1% |
| Net Income | -$173,502 | -$59,620 | -$116,875 | -$92,086 |
| % Margin | -432.1% | -89% | -515.6% | -1,019.8% |
| EPS Diluted | -2.51 | -1.22 | -2.69 | -2.25 |
| % Growth | -105.7% | 54.6% | -19.6% | – |
| Operating Cash Flow | -$2,184 | -$66,681 | -$86,152 | -$83,528 |
| Capital Expenditures | $0 | -$25,658 | -$21,182 | -$16,230 |
| Free Cash Flow | -$2,184 | -$92,339 | -$107,334 | -$99,758 |